chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blister, Dry eye, Facial paralysis, Glossodynia
Clinical narrative: Patient is a 65 y.o. male with pmhx with HLD, SNHL(uses bilateral hearing aids), here today for  evaluation of facial nerve palsy. Patient had first shot of pfizer COVID vaccine in March 2021 then  developed shingles on the mentum (L>R) which was treated with anti-virals and steroids. After his  second dose of pfizer COVID vaccine he developed complete facial nerve paralysis. Onset was left sided,  sudden, associated with left sided pain at the lower mandible, complete inability to move any left sided  facial muscles with incomplete eye closure. Improved since. Now with persistent tingling and pain (pins  and needles) on the left tongue, mandible. More noticeable later in the evening. * See Page 2 Is on pregabalin to help with this. Eye dried out and then vision feels blurry. Doctor pulgged left lower punctum but still with intermittent issues. Still feels like left corner of the mouth droops, his left eye corner droops. Left neck tightness when smiles.  (-) trauma; no previous such episodes  PLAN: o The timeline of his left facial paralysis is interesting.  Even though the zoster preceded his facial paralysis with the second dose of his vaccine between the two, I would still classify this as Ramsay Hunt over Bell's palsy.  That said, from a Ramsay Hunt perspective his recovery is remarkably ideal.  He appears to have early facial muscular spasticity most notable in his platysma with smiling.  He still appears to have some weakness, particularly with delaying eye closure and blink as well as oral commissure excursion.  We had a long discussion about the development of synkinesis and facial spasticity. We discussed the fact that recovery is a multiyear process for which she is only in the first 4 to 5 months. o Facial muscle retraining for synkinesis- refer to specialist o Placement into facial nerve disorders multidisciplinary treatment program per specialist. o Plan for future chemodenervation related to facial spasticity related to recovery from facial nerve paralysis on the left.  Plan the following injection pattern: platysma 25u and approx 2 u to dao, 3-5 to oculi, 2u to nasalis/ds, 5 u to mentalis.  This pattern is subject to change as he is currently referred to start therapy which will help the irregular contraction patterns and thus his botulinum toxin requirement.  Injection pattern is also subject to change as there is advancement in recovery, either good or bad, ie worsening of spasticity in the first 2-3 years of recovery. o Discussed tingling.  Cutaneous sensation c/w pattern of vesicles related to shingles.  Oral/tongue tingling likely related to chorda tympanil involvement. o lyrica for neuralgia per pcp
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster oticus, Lagophthalmos, Muscle spasticity, Muscle tightness, Neuralgia
Clinical narrative: Patient is a 65 y.o. male with pmhx with HLD, SNHL(uses bilateral hearing aids), here today for  evaluation of facial nerve palsy. Patient had first shot of pfizer COVID vaccine in March 2021 then  developed shingles on the mentum (L>R) which was treated with anti-virals and steroids. After his  second dose of pfizer COVID vaccine he developed complete facial nerve paralysis. Onset was left sided,  sudden, associated with left sided pain at the lower mandible, complete inability to move any left sided  facial muscles with incomplete eye closure. Improved since. Now with persistent tingling and pain (pins  and needles) on the left tongue, mandible. More noticeable later in the evening. * See Page 2 Is on pregabalin to help with this. Eye dried out and then vision feels blurry. Doctor pulgged left lower punctum but still with intermittent issues. Still feels like left corner of the mouth droops, his left eye corner droops. Left neck tightness when smiles.  (-) trauma; no previous such episodes  PLAN: o The timeline of his left facial paralysis is interesting.  Even though the zoster preceded his facial paralysis with the second dose of his vaccine between the two, I would still classify this as Ramsay Hunt over Bell's palsy.  That said, from a Ramsay Hunt perspective his recovery is remarkably ideal.  He appears to have early facial muscular spasticity most notable in his platysma with smiling.  He still appears to have some weakness, particularly with delaying eye closure and blink as well as oral commissure excursion.  We had a long discussion about the development of synkinesis and facial spasticity. We discussed the fact that recovery is a multiyear process for which she is only in the first 4 to 5 months. o Facial muscle retraining for synkinesis- refer to specialist o Placement into facial nerve disorders multidisciplinary treatment program per specialist. o Plan for future chemodenervation related to facial spasticity related to recovery from facial nerve paralysis on the left.  Plan the following injection pattern: platysma 25u and approx 2 u to dao, 3-5 to oculi, 2u to nasalis/ds, 5 u to mentalis.  This pattern is subject to change as he is currently referred to start therapy which will help the irregular contraction patterns and thus his botulinum toxin requirement.  Injection pattern is also subject to change as there is advancement in recovery, either good or bad, ie worsening of spasticity in the first 2-3 years of recovery. o Discussed tingling.  Cutaneous sensation c/w pattern of vesicles related to shingles.  Oral/tongue tingling likely related to chorda tympanil involvement. o lyrica for neuralgia per pcp
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in jaw, Paraesthesia, Paraesthesia oral, Synkinesis, Vision blurred
Clinical narrative: Patient is a 65 y.o. male with pmhx with HLD, SNHL(uses bilateral hearing aids), here today for  evaluation of facial nerve palsy. Patient had first shot of pfizer COVID vaccine in March 2021 then  developed shingles on the mentum (L>R) which was treated with anti-virals and steroids. After his  second dose of pfizer COVID vaccine he developed complete facial nerve paralysis. Onset was left sided,  sudden, associated with left sided pain at the lower mandible, complete inability to move any left sided  facial muscles with incomplete eye closure. Improved since. Now with persistent tingling and pain (pins  and needles) on the left tongue, mandible. More noticeable later in the evening. * See Page 2 Is on pregabalin to help with this. Eye dried out and then vision feels blurry. Doctor pulgged left lower punctum but still with intermittent issues. Still feels like left corner of the mouth droops, his left eye corner droops. Left neck tightness when smiles.  (-) trauma; no previous such episodes  PLAN: o The timeline of his left facial paralysis is interesting.  Even though the zoster preceded his facial paralysis with the second dose of his vaccine between the two, I would still classify this as Ramsay Hunt over Bell's palsy.  That said, from a Ramsay Hunt perspective his recovery is remarkably ideal.  He appears to have early facial muscular spasticity most notable in his platysma with smiling.  He still appears to have some weakness, particularly with delaying eye closure and blink as well as oral commissure excursion.  We had a long discussion about the development of synkinesis and facial spasticity. We discussed the fact that recovery is a multiyear process for which she is only in the first 4 to 5 months. o Facial muscle retraining for synkinesis- refer to specialist o Placement into facial nerve disorders multidisciplinary treatment program per specialist. o Plan for future chemodenervation related to facial spasticity related to recovery from facial nerve paralysis on the left.  Plan the following injection pattern: platysma 25u and approx 2 u to dao, 3-5 to oculi, 2u to nasalis/ds, 5 u to mentalis.  This pattern is subject to change as he is currently referred to start therapy which will help the irregular contraction patterns and thus his botulinum toxin requirement.  Injection pattern is also subject to change as there is advancement in recovery, either good or bad, ie worsening of spasticity in the first 2-3 years of recovery. o Discussed tingling.  Cutaneous sensation c/w pattern of vesicles related to shingles.  Oral/tongue tingling likely related to chorda tympanil involvement. o lyrica for neuralgia per pcp
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: C-reactive protein increased, Chronic papillomatous dermatitis, Epiretinal membrane, Eye infection fungal, Interleukin therapy
Clinical narrative: Aggressive fungal infection in her left eye 16 weeks after second dose of Moderna Covid-19 vaccine. Epiretinal membrane s/p PRK and had complication with pseudoepithelization and is on abx and anti-fungals and PRP. Treatment: Monifloxacin 0.5 % eye drops, doxycycline 100 mg
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Photorefractive keratectomy
Clinical narrative: Aggressive fungal infection in her left eye 16 weeks after second dose of Moderna Covid-19 vaccine. Epiretinal membrane s/p PRK and had complication with pseudoepithelization and is on abx and anti-fungals and PRP. Treatment: Monifloxacin 0.5 % eye drops, doxycycline 100 mg
Age: 1.33
Sex: M
Vaccine: TDAP
Symptoms: Wrong product administered
Clinical narrative: Tdap given instead of Dtap
Sex: M
Vaccine: TDAP
Symptoms: Wrong product administered
Clinical narrative: Tdap given instead of Dtap
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV, PPV
Symptoms: Chills, Gait inability, Musculoskeletal stiffness, Nervousness, Pain in extremity
Clinical narrative: 12 hours after shots, his right leg was painful. He had chills, shaking and tremors. he was unable to walk due to pain in r. leg.   Sat 6/5 thru Wed 6/9 No fever, no rash, no vomiting, no diarrhea -Give Tylenol/ibuprofen, ice it, ace wrap, rest #18  Patient was nervous and struggling with mom and staff.         Staff held patients legs while injections were given.         Legs were tense.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV, PPV
Symptoms: Tremor
Clinical narrative: 12 hours after shots, his right leg was painful. He had chills, shaking and tremors. he was unable to walk due to pain in r. leg.   Sat 6/5 thru Wed 6/9 No fever, no rash, no vomiting, no diarrhea -Give Tylenol/ibuprofen, ice it, ace wrap, rest #18  Patient was nervous and struggling with mom and staff.         Staff held patients legs while injections were given.         Legs were tense.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Dysstasia, Gait inability, Guillain-Barre syndrome, Lumbar puncture abnormal
Clinical narrative: Vaccine was given in right arm. The adverse reaction occured weeks later.  Reaction started with extreme nausea and vomiting.  Patient went to an Urgent Care Facility.  Doctor referred patient to emergency room.  Patient collapsed on April 22, 2021 and was unable to walk or even pull herself up.  Patient was taken to emergency room and admitted.  Patient lost the use of her lower  half of her body.  She was unable to stand, walk, move her legs or feet.  Patient was given a spinal tap after 2 weeks and was diagnosed with Guillian Barre Syndrome.  The patient was treated for five days with gamma globulin intravenously.  The patient was in two different hospitals and a nursing home facility for a period of three months.  Patient is home now still recovering.  She requires outpatient Physical Therapy. No other vaccines were given to patient prior to Pfizer vaccine. She has had no adverse reactions to the flu vaccine.  She has taken the flu vaccine for approximately five years annually with no reaction.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Musculoskeletal disorder, Nausea, Syncope, Vomiting
Clinical narrative: Vaccine was given in right arm. The adverse reaction occured weeks later.  Reaction started with extreme nausea and vomiting.  Patient went to an Urgent Care Facility.  Doctor referred patient to emergency room.  Patient collapsed on April 22, 2021 and was unable to walk or even pull herself up.  Patient was taken to emergency room and admitted.  Patient lost the use of her lower  half of her body.  She was unable to stand, walk, move her legs or feet.  Patient was given a spinal tap after 2 weeks and was diagnosed with Guillian Barre Syndrome.  The patient was treated for five days with gamma globulin intravenously.  The patient was in two different hospitals and a nursing home facility for a period of three months.  Patient is home now still recovering.  She requires outpatient Physical Therapy. No other vaccines were given to patient prior to Pfizer vaccine. She has had no adverse reactions to the flu vaccine.  She has taken the flu vaccine for approximately five years annually with no reaction.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test abnormal, Burning sensation, Guillain-Barre syndrome, Hypoaesthesia, Lumbar puncture abnormal
Clinical narrative: Guillain-Barre syndrome; Fever; Chills; Muscle ache; This is a Spontaneous report from a contactable pharmacist. A 41-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EJ1685 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 09Jan2021 (age at vaccination: 41 years), as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EJ1685 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on an unspecified date, as a single dose for COVID-19 immunization. Vaccine was not administered at military facility. Caller was a pharmacist who stated that she was involved in administering the Pfizer COVID-19 vaccines at her work and due to the increase in concerns about Guillain-Barre syndrome developing with the it prompted her to call Pfizer because she remembers 1 patient who was diagnosed with Guillain-Barre syndrome after receiving the second dose on 15Jan2021 and she remembers 2 patients who developed Bell's Palsy after receiving their first doses of the Pfizer COVID-19 vaccines and they were not given the second doses due to these adverse events. On the date of the second dose of the Pfizer Covid 19 Vaccine the patient developed fever, chills, and muscle aches. On 15Jan2021 the patient went to the emergency room and was hospitalized on an unspecified date in Jan2021. The patient was admitted to the hospital for 5 days and treated with IV Ig. The caller stated that the last time that she spoke with the patient, the patient was recovered but was still experiencing some numbness and tingling. The patient had a spinal tap and blood work on 15Jan2021 and 16Jan2021; the caller did not have the results of these tests. The adverse events required a visit to emergency room. The patient was discharged form hospital on an unspecified date in Jan2021. Outcome of the event Guillain-Barre syndrome was recovered on an unspecified date in 2021 and all other events was recovered on 17Jan2021.; Sender's Comments: Based on the information currently available in narrative , a possible contributory role of the suspect vaccine BNT162B2 or comirnarty in triggering the onset of reported events of  Guillain-Barre syndrome , muscle ache, cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging abnormal, Pain in extremity, Paraesthesia
Clinical narrative: Guillain-Barre syndrome; Fever; Chills; Muscle ache; This is a Spontaneous report from a contactable pharmacist. A 41-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EJ1685 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 09Jan2021 (age at vaccination: 41 years), as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EJ1685 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on an unspecified date, as a single dose for COVID-19 immunization. Vaccine was not administered at military facility. Caller was a pharmacist who stated that she was involved in administering the Pfizer COVID-19 vaccines at her work and due to the increase in concerns about Guillain-Barre syndrome developing with the it prompted her to call Pfizer because she remembers 1 patient who was diagnosed with Guillain-Barre syndrome after receiving the second dose on 15Jan2021 and she remembers 2 patients who developed Bell's Palsy after receiving their first doses of the Pfizer COVID-19 vaccines and they were not given the second doses due to these adverse events. On the date of the second dose of the Pfizer Covid 19 Vaccine the patient developed fever, chills, and muscle aches. On 15Jan2021 the patient went to the emergency room and was hospitalized on an unspecified date in Jan2021. The patient was admitted to the hospital for 5 days and treated with IV Ig. The caller stated that the last time that she spoke with the patient, the patient was recovered but was still experiencing some numbness and tingling. The patient had a spinal tap and blood work on 15Jan2021 and 16Jan2021; the caller did not have the results of these tests. The adverse events required a visit to emergency room. The patient was discharged form hospital on an unspecified date in Jan2021. Outcome of the event Guillain-Barre syndrome was recovered on an unspecified date in 2021 and all other events was recovered on 17Jan2021.; Sender's Comments: Based on the information currently available in narrative , a possible contributory role of the suspect vaccine BNT162B2 or comirnarty in triggering the onset of reported events of  Guillain-Barre syndrome , muscle ache, cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Chills, Guillain-Barre syndrome, Lumbar puncture, Myalgia
Clinical narrative: Guillain-Barre syndrome; Fever; Chills; Muscle ache; This is a Spontaneous report from a contactable pharmacist. A 41-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EJ1685 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 09Jan2021 (age at vaccination: 41 years), as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EJ1685 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on an unspecified date, as a single dose for COVID-19 immunization. Vaccine was not administered at military facility. Caller was a pharmacist who stated that she was involved in administering the Pfizer COVID-19 vaccines at her work and due to the increase in concerns about Guillain-Barre syndrome developing with the it prompted her to call Pfizer because she remembers 1 patient who was diagnosed with Guillain-Barre syndrome after receiving the second dose on 15Jan2021 and she remembers 2 patients who developed Bell's Palsy after receiving their first doses of the Pfizer COVID-19 vaccines and they were not given the second doses due to these adverse events. On the date of the second dose of the Pfizer Covid 19 Vaccine the patient developed fever, chills, and muscle aches. On 15Jan2021 the patient went to the emergency room and was hospitalized on an unspecified date in Jan2021. The patient was admitted to the hospital for 5 days and treated with IV Ig. The caller stated that the last time that she spoke with the patient, the patient was recovered but was still experiencing some numbness and tingling. The patient had a spinal tap and blood work on 15Jan2021 and 16Jan2021; the caller did not have the results of these tests. The adverse events required a visit to emergency room. The patient was discharged form hospital on an unspecified date in Jan2021. Outcome of the event Guillain-Barre syndrome was recovered on an unspecified date in 2021 and all other events was recovered on 17Jan2021.; Sender's Comments: Based on the information currently available in narrative , a possible contributory role of the suspect vaccine BNT162B2 or comirnarty in triggering the onset of reported events of  Guillain-Barre syndrome , muscle ache, cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Guillain-Barre syndrome; Fever; Chills; Muscle ache; This is a Spontaneous report from a contactable pharmacist. A 41-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EJ1685 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 09Jan2021 (age at vaccination: 41 years), as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EJ1685 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on an unspecified date, as a single dose for COVID-19 immunization. Vaccine was not administered at military facility. Caller was a pharmacist who stated that she was involved in administering the Pfizer COVID-19 vaccines at her work and due to the increase in concerns about Guillain-Barre syndrome developing with the it prompted her to call Pfizer because she remembers 1 patient who was diagnosed with Guillain-Barre syndrome after receiving the second dose on 15Jan2021 and she remembers 2 patients who developed Bell's Palsy after receiving their first doses of the Pfizer COVID-19 vaccines and they were not given the second doses due to these adverse events. On the date of the second dose of the Pfizer Covid 19 Vaccine the patient developed fever, chills, and muscle aches. On 15Jan2021 the patient went to the emergency room and was hospitalized on an unspecified date in Jan2021. The patient was admitted to the hospital for 5 days and treated with IV Ig. The caller stated that the last time that she spoke with the patient, the patient was recovered but was still experiencing some numbness and tingling. The patient had a spinal tap and blood work on 15Jan2021 and 16Jan2021; the caller did not have the results of these tests. The adverse events required a visit to emergency room. The patient was discharged form hospital on an unspecified date in Jan2021. Outcome of the event Guillain-Barre syndrome was recovered on an unspecified date in 2021 and all other events was recovered on 17Jan2021.; Sender's Comments: Based on the information currently available in narrative , a possible contributory role of the suspect vaccine BNT162B2 or comirnarty in triggering the onset of reported events of  Guillain-Barre syndrome , muscle ache, cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neck pain, Peripheral swelling
Clinical narrative: I got the injection, I had soreness of the injection site, By the end of Sunday evening I ended up feeling more pain in that arm felt like my arm was asleep and like I slept wrong. On the 28th I woke up with sharp pains signals like stabbing sharp pains, I felt like my whole left side had block. I could barely close my hands or stretch it. My hand was swollen. I could not lift my arm. I went to doctors and when the doctor lifted my arm she took pics armpit was swollen as well. The doctor gave me anti-inflammatory to try to alleviate the pain. I was extremely fatigued and tired. I traveled for my birthday and had to be in a wheelchair, I was having sweats and I was so much pain I went to the ER. The doctor in ER gave muscle relaxer and pain medication and my arm was completely swollen. And for 2 months I was fine, I felt fine except for the consistent weakness in my arm. Towards the end of April I started having consistent and chronic weakness and pain in my arm. I saw neurologist who given steroid injections and what they could see was the nerve that ran down by injection sight was pinched together instead of being expanded. The other thing that recently has come up that they discovered a hormonal imbalance and my testosterone levels are extremely high.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Blood test, Blood testosterone increased, Fatigue, Hormone level abnormal
Clinical narrative: I got the injection, I had soreness of the injection site, By the end of Sunday evening I ended up feeling more pain in that arm felt like my arm was asleep and like I slept wrong. On the 28th I woke up with sharp pains signals like stabbing sharp pains, I felt like my whole left side had block. I could barely close my hands or stretch it. My hand was swollen. I could not lift my arm. I went to doctors and when the doctor lifted my arm she took pics armpit was swollen as well. The doctor gave me anti-inflammatory to try to alleviate the pain. I was extremely fatigued and tired. I traveled for my birthday and had to be in a wheelchair, I was having sweats and I was so much pain I went to the ER. The doctor in ER gave muscle relaxer and pain medication and my arm was completely swollen. And for 2 months I was fine, I felt fine except for the consistent weakness in my arm. Towards the end of April I started having consistent and chronic weakness and pain in my arm. I saw neurologist who given steroid injections and what they could see was the nerve that ran down by injection sight was pinched together instead of being expanded. The other thing that recently has come up that they discovered a hormonal imbalance and my testosterone levels are extremely high.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hyperhidrosis, Hypoaesthesia, Injected limb mobility decreased, Injection site pain, Lymphadenopathy
Clinical narrative: I got the injection, I had soreness of the injection site, By the end of Sunday evening I ended up feeling more pain in that arm felt like my arm was asleep and like I slept wrong. On the 28th I woke up with sharp pains signals like stabbing sharp pains, I felt like my whole left side had block. I could barely close my hands or stretch it. My hand was swollen. I could not lift my arm. I went to doctors and when the doctor lifted my arm she took pics armpit was swollen as well. The doctor gave me anti-inflammatory to try to alleviate the pain. I was extremely fatigued and tired. I traveled for my birthday and had to be in a wheelchair, I was having sweats and I was so much pain I went to the ER. The doctor in ER gave muscle relaxer and pain medication and my arm was completely swollen. And for 2 months I was fine, I felt fine except for the consistent weakness in my arm. Towards the end of April I started having consistent and chronic weakness and pain in my arm. I saw neurologist who given steroid injections and what they could see was the nerve that ran down by injection sight was pinched together instead of being expanded. The other thing that recently has come up that they discovered a hormonal imbalance and my testosterone levels are extremely high.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging, Muscle tightness, Muscular weakness, Nerve compression, Pain
Clinical narrative: I got the injection, I had soreness of the injection site, By the end of Sunday evening I ended up feeling more pain in that arm felt like my arm was asleep and like I slept wrong. On the 28th I woke up with sharp pains signals like stabbing sharp pains, I felt like my whole left side had block. I could barely close my hands or stretch it. My hand was swollen. I could not lift my arm. I went to doctors and when the doctor lifted my arm she took pics armpit was swollen as well. The doctor gave me anti-inflammatory to try to alleviate the pain. I was extremely fatigued and tired. I traveled for my birthday and had to be in a wheelchair, I was having sweats and I was so much pain I went to the ER. The doctor in ER gave muscle relaxer and pain medication and my arm was completely swollen. And for 2 months I was fine, I felt fine except for the consistent weakness in my arm. Towards the end of April I started having consistent and chronic weakness and pain in my arm. I saw neurologist who given steroid injections and what they could see was the nerve that ran down by injection sight was pinched together instead of being expanded. The other thing that recently has come up that they discovered a hormonal imbalance and my testosterone levels are extremely high.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Peripheral swelling, Wheelchair user, X-ray
Clinical narrative: I got the injection, I had soreness of the injection site, By the end of Sunday evening I ended up feeling more pain in that arm felt like my arm was asleep and like I slept wrong. On the 28th I woke up with sharp pains signals like stabbing sharp pains, I felt like my whole left side had block. I could barely close my hands or stretch it. My hand was swollen. I could not lift my arm. I went to doctors and when the doctor lifted my arm she took pics armpit was swollen as well. The doctor gave me anti-inflammatory to try to alleviate the pain. I was extremely fatigued and tired. I traveled for my birthday and had to be in a wheelchair, I was having sweats and I was so much pain I went to the ER. The doctor in ER gave muscle relaxer and pain medication and my arm was completely swollen. And for 2 months I was fine, I felt fine except for the consistent weakness in my arm. Towards the end of April I started having consistent and chronic weakness and pain in my arm. I saw neurologist who given steroid injections and what they could see was the nerve that ran down by injection sight was pinched together instead of being expanded. The other thing that recently has come up that they discovered a hormonal imbalance and my testosterone levels are extremely high.
Age: 95.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebral haemorrhage, Computerised tomogram head abnormal, Death, Unresponsive to stimuli
Clinical narrative: Witnessed collapse due to ruptured cerebral aneurysm less than 24 hours after vaccination; presence of the aneurysm was well known and radiologically monitored for many years; the condition was considered clinically stable and radiologically unchanged for many years
Age: 95.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Autopsy, Condition aggravated, Ruptured cerebral aneurysm, Syncope
Clinical narrative: Witnessed collapse due to ruptured cerebral aneurysm less than 24 hours after vaccination; presence of the aneurysm was well known and radiologically monitored for many years; the condition was considered clinically stable and radiologically unchanged for many years
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Numbness in hands; Tingling in hands; Pain in right arm; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old, non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 24Mar2021 at 10:30 (at the age of 58-year-old), as a single dose for COVID-19 immunisation. Medical history included autoimmune disorder and connective tissue disease.  The patient reported of no known allergies to medications, food, or other products. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), sertraline (MANUFACTURER UNKNOWN) and statin (MANUFACTURER UNKNOWN) for an unknown indication and from an unknown date. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Mar2021, the patient experienced numbness and tingling in hands, pain in right arm. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the events numbness and tingling in hands, pain in right arm was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Carpal tunnel syndrome, Electric shock, Hypoaesthesia, SARS-CoV-2 test
Clinical narrative: Numbness in hands; Tingling in hands; Pain in right arm; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old, non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 24Mar2021 at 10:30 (at the age of 58-year-old), as a single dose for COVID-19 immunisation. Medical history included autoimmune disorder and connective tissue disease.  The patient reported of no known allergies to medications, food, or other products. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), sertraline (MANUFACTURER UNKNOWN) and statin (MANUFACTURER UNKNOWN) for an unknown indication and from an unknown date. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Mar2021, the patient experienced numbness and tingling in hands, pain in right arm. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the events numbness and tingling in hands, pain in right arm was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypoaesthesia, Pain in extremity, Paraesthesia
Clinical narrative: Numbness in hands; Tingling in hands; Pain in right arm; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old, non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 24Mar2021 at 10:30 (at the age of 58-year-old), as a single dose for COVID-19 immunisation. Medical history included autoimmune disorder and connective tissue disease.  The patient reported of no known allergies to medications, food, or other products. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), sertraline (MANUFACTURER UNKNOWN) and statin (MANUFACTURER UNKNOWN) for an unknown indication and from an unknown date. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Mar2021, the patient experienced numbness and tingling in hands, pain in right arm. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the events numbness and tingling in hands, pain in right arm was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Feeling abnormal, Headache
Clinical narrative: Dizziness; Headache; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 22Mar2021 at 10:30 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, hypothyroidism and endometriosis. The patient was allergic to shellfish. Concomitant medications included levothyroxine sodium (SYNTHROID), salbutamol (ALBUTEROL), calcium (MANUFACTURER UNKNOWN), vitamin d nos (MANUFACTURER UNKNOWN) and unspecified vitamins. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021 at 18:00, evening of the second day, the patient experienced dizziness and headache. The dizziness abates by the end of the day but was worse in the mornings. It was reported that it had not gone away despite doing vestibular exercises and was greatly exacerbated by wine, which the patient avoided now (at the time of report). The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event dizziness was not recovered at the time of report. The clinical outcome of the event headache was unknown at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Headache
Clinical narrative: Dizziness; Headache; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 22Mar2021 at 10:30 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, hypothyroidism and endometriosis. The patient was allergic to shellfish. Concomitant medications included levothyroxine sodium (SYNTHROID), salbutamol (ALBUTEROL), calcium (MANUFACTURER UNKNOWN), vitamin d nos (MANUFACTURER UNKNOWN) and unspecified vitamins. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021 at 18:00, evening of the second day, the patient experienced dizziness and headache. The dizziness abates by the end of the day but was worse in the mornings. It was reported that it had not gone away despite doing vestibular exercises and was greatly exacerbated by wine, which the patient avoided now (at the time of report). The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event dizziness was not recovered at the time of report. The clinical outcome of the event headache was unknown at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Hypersensitivity, Pruritus, Rash, Throat tightness
Clinical narrative: rash; hives; itch all over the body include face/ear/eyelids; throat stuck; chest pain; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 12Mar2021 at 16:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included acid reflux (esophageal), benign polyps on gall bladder and COVID-19 on unknown dates. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN) 40 mg, VitaminD+K (MANUFACTURER UNKNOWN), probiotic (MANUFACTURER UNKNOWN) and ibuprofen (ADVIL) from an unknown date to 25Mar2021 for unknown indications. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 11:00, the patient experienced rash, hives, itch all over the body include face/ear/eyelids and overnight experienced throat stuck and chest pain. The events resulted in emergency room/department or urgent care. Next day on 26Mar2021, went to urgent care, and therapeutic measures were taken for the reported events and included treatment with steroid tablet, Zyrtec and Benadryl 5 days. At the time of this report the patient still had minor rash, itchiness and was on Zyrtec when needed. All other medications, vitamins and Advil were stopped on 25Mar2021. The clinical outcome of the events rash and itch all over the body include face/ear/eyelids were not recovered at the time of this report and the outcome of the events hives, throat stuck and chest pain were recovered with sequelae on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Toothache, Urticaria
Clinical narrative: rash; hives; itch all over the body include face/ear/eyelids; throat stuck; chest pain; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 12Mar2021 at 16:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included acid reflux (esophageal), benign polyps on gall bladder and COVID-19 on unknown dates. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN) 40 mg, VitaminD+K (MANUFACTURER UNKNOWN), probiotic (MANUFACTURER UNKNOWN) and ibuprofen (ADVIL) from an unknown date to 25Mar2021 for unknown indications. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 11:00, the patient experienced rash, hives, itch all over the body include face/ear/eyelids and overnight experienced throat stuck and chest pain. The events resulted in emergency room/department or urgent care. Next day on 26Mar2021, went to urgent care, and therapeutic measures were taken for the reported events and included treatment with steroid tablet, Zyrtec and Benadryl 5 days. At the time of this report the patient still had minor rash, itchiness and was on Zyrtec when needed. All other medications, vitamins and Advil were stopped on 25Mar2021. The clinical outcome of the events rash and itch all over the body include face/ear/eyelids were not recovered at the time of this report and the outcome of the events hives, throat stuck and chest pain were recovered with sequelae on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Oropharyngeal discomfort, Pruritus, Rash, Urticaria
Clinical narrative: rash; hives; itch all over the body include face/ear/eyelids; throat stuck; chest pain; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 12Mar2021 at 16:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included acid reflux (esophageal), benign polyps on gall bladder and COVID-19 on unknown dates. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN) 40 mg, VitaminD+K (MANUFACTURER UNKNOWN), probiotic (MANUFACTURER UNKNOWN) and ibuprofen (ADVIL) from an unknown date to 25Mar2021 for unknown indications. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 11:00, the patient experienced rash, hives, itch all over the body include face/ear/eyelids and overnight experienced throat stuck and chest pain. The events resulted in emergency room/department or urgent care. Next day on 26Mar2021, went to urgent care, and therapeutic measures were taken for the reported events and included treatment with steroid tablet, Zyrtec and Benadryl 5 days. At the time of this report the patient still had minor rash, itchiness and was on Zyrtec when needed. All other medications, vitamins and Advil were stopped on 25Mar2021. The clinical outcome of the events rash and itch all over the body include face/ear/eyelids were not recovered at the time of this report and the outcome of the events hives, throat stuck and chest pain were recovered with sequelae on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.